Reference | Name | Unity | Provider | Aplication | Clonality | Host | Reactivity | Price | Tech.Sheet |
---|---|---|---|---|---|---|---|---|---|
Ab00135-11.0 | Anti-Beta-galactosidase [13R4] | 200 ug | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
Ab00122-15.0-BT | Anti-CD3 epsilon [OKT-3 (muromonab)] | 500 ug | Absolute Antibody | FC | Human | Request Quotation | Request | ||
Ab00135-8.1-BT | Anti-Beta-galactosidase [13R4] | 1 mg | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
Ab01474-10.3 | Anti-Advanced Glycation End Products (AGE), Methylgloxal (MG) [3D11] | 200 ug | Absolute Antibody | ELISA; IHC; WB | Human; Mouse; Rat | Request Quotation | Request | ||
Ab03226-10.3-BT | Anti-ADAMTS5 [7B4] | 1 mg | Absolute Antibody | Crystallography; IHC; in vivo; inhibition | Human; mouse | Request Quotation | Request | ||
Ab00735-2.3 | Anti-ADAMts13 [1-420 scFv] | 200 ug | Absolute Antibody | Inhibit | Human; Mouse | Request Quotation | Request | ||
Ab00136-2.0 | Anti-V5 epitope tag [SV5-P-K] | 200 ug | Absolute Antibody | ELISA; IF; IHC-Fr; IP; RIA; WB | Paramyxovirus Simian Virus 5 | Request Quotation | Request | ||
Ab02447-10.3-BT | Anti-Alpha Actinin 4 [Ab01AA4] | 1 mg | Absolute Antibody | ELISA; IHC; IP | Human | Request Quotation | Request | ||
Ab00134-2.0-VPB | Anti-EGFR [7A7] | 100 mg | Absolute Antibody | IHC; in vivo; FC; IF | Human; Mouse | Request Quotation | Request | ||
Ab00735-10.6 | Anti-ADAMts13 [1-420 scFv] | 100 ug | Absolute Antibody | Inhibit | Human; Mouse | Request Quotation | Request | ||
Ab00123-23.0 | Anti-CD16/CD32 [2.4G2] | 200 ug | Absolute Antibody | FC; IF; IP; IHC; Block | Mouse | Request Quotation | Request | ||
Ab00112-1.1 | Anti-CD3 epsilon [UCHT1] | 200 ug | Absolute Antibody | FC; IHC | Human | Request Quotation | Request | ||
Ab00113-23.0-BT | Anti-CD4 [W3/25] | 1 mg | Absolute Antibody | FC; IHC; IHC | Rat | Request Quotation | Request | ||
Ab00122-23.0 | Anti-CD3 epsilon [OKT-3 (muromonab)] | 200 ug | Absolute Antibody | FC | Human | Request Quotation | Request | ||
Ab00118-23.0-BT | Anti-CD200R [OX108] | 1 mg | Absolute Antibody | FC | Human | Request Quotation | Request | ||
Ab00128-1.1 | Anti-CD38 [HB7] | 200 ug | Absolute Antibody | FC; IP | Human | Request Quotation | Request | ||
Ab00110-23.0-BT | Anti-CD134 [OX86] | 1 mg | Absolute Antibody | FC; agonist; IF; ELISA | Mouse | Request Quotation | Request | ||
Ab00134-2.0-VPT | Anti-EGFR [7A7] | 10 mg | Absolute Antibody | IHC; in vivo; FC; IF | Human; Mouse | Request Quotation | Request | ||
Ab00735-1.6-BT | Anti-ADAMts13 [1-420 scFv] | 500 ug | Absolute Antibody | Inhibit | Human; Mouse | Request Quotation | Request | ||
Ab00114-23.0 | Anti-HLA Class 1 [W6/32] | 200 ug | Absolute Antibody | FC; ELISA; IF; IP; IHC | Human | Request Quotation | Request | ||
Ab00131-5.0 | Anti-D-Dimer [3B6] | 200 ug | Absolute Antibody | LFA (Collodial Gold); ELISA; Latex and RBC Agglu | Human | Request Quotation | Request | ||
Ab00124-8.1-BT | Anti-CD52 [Alemtuzumab (Campath-1H)] | 1 mg | Absolute Antibody | Cytotoxicity Assay; ELISA; IHC-Fr; IHC-P; in vivo; | Human; Rhesus Monkey; Cynomolgus Monkey | Request Quotation | Request | ||
Ab00123-8.1-VPT | Anti-CD16/CD32 [2.4G2] | 10 mg | Absolute Antibody | FC; IF; IP; IHC; Block | Mouse | Request Quotation | Request | ||
Ab00143-1.1-BS | Anti-P-glycoprotein [MRK16] | 1 mg | Absolute Antibody | FC; IF; IP | Human | Request Quotation | Request | ||
Ab00118-1.1-BT | Anti-CD200R [OX108] | 1 mg | Absolute Antibody | FC | Human | Request Quotation | Request | ||
Ab00909-7.4 | Anti-acetylcholine receptor [mAb198] | 200 ug | Absolute Antibody | Crystallisation; WB; ELISA; IP; IHC; deplete | Human | Request Quotation | Request | ||
Ab00121-22.0 | Anti-CD3 epsilon [500A2] | 200 ug | Absolute Antibody | FC; Activate | Mouse | Request Quotation | Request | ||
Ab00135-6.1 | Anti-Beta-galactosidase [13R4] | 200 ug | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
Ab00123-23.0-BT | Anti-CD16/CD32 [2.4G2] | 1 mg | Absolute Antibody | FC; IF; IP; IHC; Block | Mouse | Request Quotation | Request | ||
Ab00146-16.0 | Anti-TNF alpha [cA2 (Infliximab)] | 50 ug | Absolute Antibody | ELISA; in vivo; FC | Human | Request Quotation | Request | ||
Ab00127-1.1 | Anti-CD34 [My10] | 200 ug | Absolute Antibody | FC; IP; IHC | Human | Request Quotation | Request | ||
Ab00122-19.0 | Anti-CD3 epsilon [OKT-3 (muromonab)] | 50 ug | Absolute Antibody | FC | Human | Request Quotation | Request | ||
Ab00113-1.1-BT | Anti-CD4 [W3/25] | 1 mg | Absolute Antibody | FC; IHC; IHC | Rat | Request Quotation | Request | ||
Ab00146-10.0 | Anti-TNF alpha [cA2 (Infliximab)] | 200 ug | Absolute Antibody | ELISA; in vivo; FC | Human | Request Quotation | Request | ||
Ab00135-5.0-BT | Anti-Beta-galactosidase [13R4] | 1 mg | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
Ab01474-2.3-BT | Anti-Advanced Glycation End Products (AGE), Methylgloxal (MG) [3D11] | 1 mg | Absolute Antibody | ELISA; IHC; WB | Human; Mouse; Rat | Request Quotation | Request | ||
Ab00735-10.3-BT | Anti-ADAMts13 [1-420 scFv] | 1 mg | Absolute Antibody | Inhibit | Human; Mouse | Request Quotation | Request | ||
Ab00138-1.1 | Anti-Insulin receptor alpha [83-7] | 200 ug | Absolute Antibody | ELISA; IHC-P; IP | Human | Request Quotation | Request | ||
Ab00127-1.1-BT | Anti-CD34 [My10] | 1 mg | Absolute Antibody | FC; IP; IHC | Human | Request Quotation | Request | ||
Ab00128-23.0 | Anti-CD38 [HB7] | 200 ug | Absolute Antibody | FC; IP | Human | Request Quotation | Request | ||
Ab02189-10.3-BT | Anti-Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 [32C8_71] | 1 mg | Absolute Antibody | ELISA; SPR; DSF | Human | Request Quotation | Request | ||
Ab00137-2.0-BT | Anti-Insulin Receptor alpha [83-14] | 1 mg | Absolute Antibody | ELISA; IF; IP; WB; IHC | Human; Bovine; Pig; Sheep | Request Quotation | Request | ||
Ab03057-1.29-BS | Anti-Adeno associated virus [A20] | 1 mg | Absolute Antibody | IP; IF; ELISA; Neutralizing | Adeno-associated virus 2 | Request Quotation | Request | ||
Ab00113-1.1 | Anti-CD4 [W3/25] | 200 ug | Absolute Antibody | FC; IHC; IHC | Rat | Request Quotation | Request | ||
Ab00110-6.1-VPT | Anti-CD134 [OX86] | 10 mg | Absolute Antibody | FC; agonist; IF; ELISA | Mouse | Request Quotation | Request | ||
Ab00135-3.0-BT | Anti-Beta-galactosidase [13R4] | 1 mg | Absolute Antibody | WB; FC; negative control | E. Coli | Request Quotation | Request | ||
Ab00407-1.4-BT | Anti-AdiC [Fab21] | 1 mg | Absolute Antibody | ELISA | E. coli; Salmonella enterica | Request Quotation | Request | ||
Ab00122-21.0-BT | Anti-CD3 epsilon [OKT-3 (muromonab)] | 500 ug | Absolute Antibody | FC | Human | Request Quotation | Request | ||
Ab00112-10.0 | Anti-CD3 epsilon [UCHT1] | 200 ug | Absolute Antibody | FC; IHC | Human | Request Quotation | Request | ||
Ab00129-26.0-BT | Anti-CD40 [G28.5] | 1 mg | Absolute Antibody | FC; IP; IHC; activate | Human | Request Quotation | Request |